News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
Precision medicine is becoming popular in all categories of medicine and has now made its way to weight management. Scientists at NIDDK have developed new methods for prescribing and monitoring personalized weight management interventions. People who make an attempt to lose weight are often
The Centers for Disease Control and Prevention (CDC) has taken home an award for Excellence in Technology Transfer from the 2021 Federal Laboratory Consortium (FLC) awards. The FLC gave out 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response award. The
On Wednesday, January 27th, you are invited to a webinar featuring Dr. Stephan T. Stern of the Frederick National Laboratory for Cancer Research discussing a novel polymeric drug delivery platform that targets the lymphatic system and brain through scavenger receptor A1 (SR-A1) mediated transcytosis